Cancer Biology & Medicine

Papers
(The H4-Index of Cancer Biology & Medicine is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Breast cancer incidence and mortality in women in China: temporal trends and projections to 2030116
Effects of cancer on patients with COVID-19: a systematic review and meta-analysis of 63,019 participants91
Current cancer burden in China: epidemiology, etiology, and prevention91
Stimuli-responsive nanocarriers for therapeutic applications in cancer44
Predictive value of MGMT promoter methylation on the survival of TMZ treated <i>IDH</i>-mutant glioblastoma39
Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies35
Recent progress of nanotechnology-based theranostic systems in cancer treatments30
Tumorigenic bacteria in colorectal cancer: mechanisms and treatments29
Advances in lung cancer screening and early detection28
The advanced development of molecular targeted therapy for hepatocellular carcinoma27
Breast cancer screening and early diagnosis in Chinese women27
Competing endogenous RNAs in lung cancer27
Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011–2017): a multicenter retrospective study from CGGA26
Three-dimensional collagen-based scaffold model to study the microenvironment and drug-resistance mechanisms of oropharyngeal squamous cell carcinomas25
Exosome-mediated cellular crosstalk within the tumor microenvironment upon irradiation25
Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guidelines in 2022: stratification and classification25
Hypoxic microenvironment induced spatial transcriptome changes in pancreatic cancer25
Global pattern and trends of colorectal cancer survival: a systematic review of population-based registration data24
Methods for monitoring cancer cell pyroptosis23
Nanomaterial-based delivery vehicles for therapeutic cancer vaccine development23
Strategies to enhance monoclonal antibody uptake and distribution in solid tumors23
Nanotechnology assisted photo- and sonodynamic therapy for overcoming drug resistance23
Major roles of the circadian clock in cancer23
The role and its mechanism of intermittent fasting in tumors: friend or foe?23
0.31587314605713